CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- 4 Grant or award Director acquired 15,556 shares (grant or award)
- 4 Grant or award Director acquired 15,556 shares (grant or award)
- 4 Grant or award Director acquired 15,556 shares (grant or award)
- 4 Grant or award Director acquired 15,556 shares (grant or award)
- 4 Grant or award Director acquired 15,556 shares (grant or award)
- 4 Grant or award Director acquired 15,556 shares (grant or award)
- 4 Grant or award President and CCO, Inivata acquired 148,455 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 3,334 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 5,727 shares (option exercise)
- 4 Grant or award Chief Financial Officer acquired 82,305 shares (grant or award)
- 4 Grant or award President, Clinical Services acquired 30,864 shares (grant or award)
- 4 Grant or award Chief Strategy Officer acquired 82,305 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 3,209 shares at $18.29 ($58,693)
- 4 Grant or award Chief Legal Officer acquired 42,036 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 142,457 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 9,341 shares (grant or award)
- 4 Shares withheld for taxes President & COO, Lab Ops gave up 1,342 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 40,869 shares (grant or award)
Page 10 of 30 · 589 filings